R&D | pharmaphorum

Sunday 24 November 2024

Channels

Content type

Categories

Categories

Sort by

Order

R&D

News

HeLa cells

Ultragenyx is latest biotech sued over HeLa cell use

Just days after settling with Thermo Fisher for an undisclosed sum, the family of Henrietta Lacks has filed a lawsuit against Ultragenyx, another US biotech that it accuse

R&D

Diversity beauty and women

Strong solutions for increasing dermatology research diversi...

As a woman of colour, I am very careful about the skin care products I use. I must be.

News

Thermo agrees settlement with Henrietta Lacks' family

Thermo agrees settlement with Henrietta Lacks' family

The family of Henrietta Lacks, an African American woman whose cells have been used in research for decades but were allegedly harvested without her consent, has agreed to

News

Roche

Roche removes tenecteplase from phase 3 for stroke

Roche said it has removed its thrombolytic drug tenecteplase from phase 3 for for acute ischaemic stroke, along with several earlier-stage projects.

R&D

lockdown

Disease X is coming. Are we ready?

Every great disaster movie begins with a scientist being ignored.

News

Janssen celebrates positive results for JNJ-2113 in psoriasis trial

Janssen celebrates positive results for JNJ-2113 in psoriasi...

Janssen, a Johnson & Johnson company,